Researchers are working on advances in the fields of nanotechnology and biomaterials which may help develop objects that eliminate viruses automatically.
Breakthroughs in the advancements made in both fields could help fight against deadly viruses like the SARS-CoV-2 virus, which is the strain that causes Covid-19.
Scientists from the Indian Institute of Science described various factors being explored by researchers in the field to design surfaces that could fight and eliminate viruses and increase vaccine efficacy.
In their study, which was published in the APL Bioengineering journal, Kaushik Chatterjee, who is one of the authors of the study, explained that they were curious to see how biomaterials could be useful with regard to viral infections.
Biomaterials are usually engineered to mesh with other biological systems in different ways. Biomaterials may include drug delivery systems, surgical mesh, dental implants and joint replacements.
On the other hand, nanotechnology is focused on building small devices and structures at the microscopic level. It has been utilized in the medical field to target certain tissues and cells.
Researchers found that combining the two fields could help vaccines become more effective against viruses. This is not to mean that current vaccines aren’t effective, just that biomaterials-based nanoparticles would make them even more effective.
Sushma Kumari, another author of the study, stated that using biomaterials-based nanoparticles could help stimulate the immune cells which give rise to antibodies during vaccination. She explained that the particles would help make the cells more responsive to protein, which would prompt them to secrete more antibodies.
Concurrently, researchers are also looking into the various ways in which technology can be used to limit the spread of viruses. Presently, the methods used to disinfect surfaces in public areas, from ultraviolet light to aerosols to normal cleaning, require a lot of effort and time.
Bioengineering technologies could help develop antiviral surfaces which could disinfect themselves, thus eliminating the time it takes an individual to clean a surface. Chatterjee noted that viruses usually ended up on surfaces as droplets, which is how a virus spreads when the next person touches the surface with virus droplets on it and picks up the disease.
The study’s authors maintain that while this research is still in its early stages, putting a natural charge on a surface or designing one at the nanotech-level would enable the creation of other items like hospital beds, PPE suits and masks which could naturally eliminate a virus.
Still on the subject of R&D to address the current threats to human health, CNS Pharmaceuticals Inc. (NASDAQ: CNSP) has opted to focus on finding remedies to the cancers which affect the neurological system, especially the brain. Therapies in this segment are projected to be worth $3.4 billion annually by 2025, presenting massive opportunities for growth by CNS Pharmaceuticals.
NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP
About BioMedWire
BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)
For more information, please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com
BioMedWire is part of the InvestorBrandNetwork.